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Asthma is an inflammatory disease associated with chronic 
perturbation of homeostatic mechanisms, leading to 
alterations in the structure of the airway walls, termed 
airway remodeling (AR).  Lung fibrosis is characterized by 
increased deposition of extracellular matrix (ECM) proteins, 
especially collagens, and enhanced proliferation and 
activation of fibroblasts, and, ultimately, distortion of 
normal lung architecture and loss of respiratory function.   
L-arginine is a key precursor of nitric oxide and proline, an 
amino acid enriched in collagen.  Arginase, which converts L-
arginine into L-ornithine and urea, is a key enzyme of the 
urea cycle in the liver, but it is also expressed in cells and 
tissues that lack a complete urea cycle, including the lung.  
Arginase exists as two distinct isoenzymes, arginase I and II, 
which are encoded by different genes.  Arginase I isoenzyme 
is a cytosolic enzyme and is the predominant isoform in the 
liver, where it is highly expressed [3].  Even though low 
levels of arginase II have been detected in liver as well [4], 
this mitochondrial enzyme is mainly expressed in 
extrahepatic tissue [3]. 
Arginase isoenzymes and the downstream enzymes ornithine 
decarboxylase (ODC) and ornithine aminotransferase (OAT) 
are key regulators of critical processes associated with 
asthma including AR, cell hyperplasia and collagen deposition 
and have been implicated in the hyperplastic and fibrotic 
changes of AR, respectively. 
One of the biological functions of arginase II may be 
regulation of the synthesis of nitric oxide (NO) by means of 
competition with NO synthase (NOS) for the common 
substrate, L-arginine (Figure 1). In addition, extrahepatic 
arginase may be involved in tissue repair processes through 
the synthesis of L-ornithine.  Thus, L-ornithine is a precursor 
of polyamines and L-proline, which are involved in cell 








Introduction: Airway remodeling (AR) in asthma is characterized by 
increased airway smooth muscle mass, subepithelial fibrosis, 
epithelial changes, and increased numbers of fibroblasts and 
myofibroblasts [1]. Established AR is resistant to current asthma 
therapies and can lead to irreversible airflow limitation, thereby 
increasing the severity of asthma [2].   
Hypothesis: We hypothesized that L-arginine metabolism is altered in 
AR, ultimately affecting collagen synthesis which may be evidenced 
by upregulation of expression of genes involved in arginine 
metabolism.  
Methods: We investigated expressions of key regulatory enzymes in 
the arginine pathway: arginase I, arginase II, ODC, and OAT proteins 
by Western blot and cell immunochemistry in human lung fibroblast 
(HLF) from normal (NHLF) and diseased (DHLF) asthmatic donors. 
Results: Positive cell staining signal was observed for arginase I, 
arginase II, ODC, and OAT in NHLF and DHLF with or without 24h 
acetylsalicylic acid treatment. Only OAT was detected in NHLF and 
DHLF via Western blot. 
Conclusion: Arginase I, arginase II, ODC, and OAT are present in NHLF 
and DHLF with or without acetylsalicylic acid (ASA) treatment as 
shown via cell immunochemistry. Levels of protein other than OAT 
could not be quantified in NHLF or DHLF via Western blot. Further 




In both normal and diseased human lung fibroblasts with or without ASA 
treatment, arginase I, arginase II, ODC and OAT were detected via cell 
immunochemistry. The MitoTracker staining enabled us to compare 
localization of mitochondria and localization of proteins of interest.  
OAT was mostly detected in mitochondrial NHLF and DHLF protein 
fractions by Western blotting, however, arginase I, arginase II, and ODC 
were not detected. Further refinement of the Western blot technique is 
required in order to provide more accurate quantification of protein 
levels of arginase I, arginase II, ODC, and OAT.  
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Cell Culture 
Normal and diseased asthmatic human lung fibroblasts were purchased 
from Lonza. Cells were cultured in Dulbecco’s Modified Eagle Medium 
(Cellgro) containing 10% FBS. Passages 2-15 were used. 
 
Cell Lysis and Protein Quantification 
1 x 106 cells were added to 100 mm plates for 24h at 37°C, cells were 
treated or not treated with 10 mM acetylsalicylic acid (Sigma-Aldrich). 
After 24h incubation at 37°C, cells were scraped and collected. Cells 
were lysed with RIPA buffer containing protease inhibitors or with 
Mitochondrial Protein Isolation Buffer (AMRESCO) containing protease 
inhibitors. Protein concentrations were quantified in the same lysis 
buffers using the Pierce BSA Protein Assay Kit. Concentrations were 
measured at 540 nm. 
 
SDS-PAGE and Western Blot 
Proteins were denatured with 2X SDS buffer at 95°C. Samples were 
loaded onto 4-15% gradient Mini-PROTEAN TGX Gels. BIO-RAD Precision 
Pl us WesternC standards were also included on the gels. Gels were 
run in 1x TGS buffer for ~1h at 125V. Proteins were transferred onto 
nitrocellulose membranes via the Invitrogen iBlot system. Membranes 
were incubated overnight at 4°C in Pierce Fast Western antibody 
diluent containing the primary antibody against the protein of 
interest. Blots were performed for Arginase I, Arginase II, Ornithine 
Decarboxylase (ODC), Ornithine Aminotransferase (OAT), β-Tubulin, 
and Cytochrome C Oxidase IV (COXIV). All antibodies were supplied by 
Santa Cruz Biotechnology. Blots were washed in PBS-Tween-20 
(SigmaAldrich), and then incubated for 10 minutes at 4°C in antibody 
diluent containing Fast Western Optimized HRP Reagent and BIO-RAD 
Precision Protein StrepTactin-HRP Conjugate. Blots were again washed 
in PBS-Tween-20. Blots were visualized using Clarity ECL Western 
Substrate (BIO-RAD).  
 
Cell Staining 
2.5 x 105 cells were added to plate wells containing EtOH-washed 
glass coverslips. After 24h, cells were treated or not treated with 10 
mM acetylsalicylic acid. After 48h incubation at 37°C, cells were 
washed with serum-free DMEM. Cells were then incubated with 
MitoTracker Orange CM-H2TMRos (Invitrogen) for 15 min at 37°C. Cells 
were then fixed for 30 min at RT with CytoFix (BD). Cells were washed 
with 1X PBS and left to sit in PBS ON at 4°C. 1X PermWash (BD) was 
then added to cells for 30 min at RT. Primary antibody in PermWash 
was added to cells, which were then covered and incubated at 37°C 
for 2h. Primary antibodies used were against Arginase I, Arginase II, 
ODC, and OAT, and were the same antibodies used for Western blot. 
Cells were kept ON at 4°C. Cells were washed with 1X PBS. Cells were 
then treated with PermWash and secondary antibody (Invitrogen 
AlexaFluor 488) for 2h at 37°C. Cells were washed with 1X PBS. Glass 
slides were labelled, and EMS DAPI FluoroGel II was added to the 
slides. Coverslips were flipped onto the Fluorogel and sealed with 
clear nail polish. Slides were examined using confocal microscopy 
utilizing 360 nm, 488 nm, and 554 nm wavelengths to view nuclei, 
protein of interest, and mitochondria, respectively.  
 
Figure 2. Expression of arginase I, arginase II, ODC and OAT in DHLF or NHLF, untreated or treated with 10 mM Acetylsalicylic Acid (ASA) for 24h. 
Immunofluorescent detection of the protein shown in green. Nuclei counterstained with 4’6-diamidino-2-phenlindole (DAPI) shown in blue. 
Mitochondria counterstained with MitoTracker Orange (CM-H2TMRos).  All three stains superimposed (merged). 
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Figure 1: L-arginine metabolism and its role in asthma 
airway remodeling 
Figure 3. Presence of different proteins in NHLF and DHLF detected via Western blot. Mitochondrial and cytosolic fractions of NHLF and DHLF 
were analyzed for presence of arginase I (35 KDa), arginase II (37 KDa), ODC (53 KDa), and OAT (46 KDa) using Western blotting. β-Tubulin was 
used to show relative amounts of protein loaded.  Positive controls for the proteins of interest were included. 
